FDA questions efficacy of cholesterol drug and hints at potential safety issues: http://t.co/EBk1wrdR
FDA publishes results of first study of three on ADHD drugs' relation to cardiac events: http://t.co/UW74zzmH
Experts were 'certain' about opinions at trial and appellate court says that's ok: http://t.co/Dh5DnNk2
Parkinson's therapy Azilect seen as effective in treating symptoms but not preventing underlying disease: http://t.co/uu43hFRX
Treating physicians restricted from discussing causation unless qualified as experts: http://t.co/WrkOmIzB
Qualitest announces recall of oral contraceptives; packaging errors could harm patients says FDA: http://t.co/zrHLvnGk
Specific causation not addressed by plaintiffs' experts and dismissal of plaintiffs' suit is upheld on appeal: http://t.co/2FriUeWM
Expert may testify for plaintiff despite recent consulting engagement for defendant: http://t.co/Jp8QFKTu
FDA follows up on study to determine link between birth control and blood clot risk: http://t.co/oROmdXO4
Off-label use of antipsychotic drugs seen as rising with questionable benefits: http://t.co/B1GIFJM1
Texas Supreme Court raises the bar for showing injury alleged to be caused by drug: http://t.co/rhUu1PWR
